Emcure Pharms Ltd Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for EMCURE PHARMS LTD, and what generic and branded alternatives to EMCURE PHARMS LTD drugs are available?
EMCURE PHARMS LTD has thirty-one approved drugs.
There is one tentative approval on EMCURE PHARMS LTD drugs.
Drugs and US Patents for Emcure Pharms Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Emcure Pharms Ltd | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 204618-001 | Aug 13, 2014 | AP | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Emcure Pharms Ltd | ZOLEDRONIC ACID | zoledronic acid | INJECTABLE;INTRAVENOUS | 201801-001 | Mar 29, 2013 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Emcure Pharms Ltd | METOCLOPRAMIDE | metoclopramide hydrochloride | INJECTABLE;INJECTION | 204756-001 | Dec 20, 2013 | AP | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Emcure Pharms Ltd | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 202063-002 | Sep 11, 2012 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Emcure Pharms Ltd | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 202275-001 | Oct 31, 2013 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Emcure Pharms Ltd | PROPOFOL | propofol | INJECTABLE;INJECTION | 206408-001 | Oct 12, 2021 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.